gb004
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 24, 2019 (NCT03860896)
Timeline
Indications
Studied for
Mechanism of action
- Hypoxia-inducible factor 1-alphaINHIBITOR
HIF1A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04556383 | Phase 2 | Oct 19, 2020 | Gossamer Bio Inc. |
| NCT03860896 | Phase 1 | Apr 24, 2019 | Gossamer Bio Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gossamer Bio Inc. | For profit | 2 | 2 | 2 | 2019 |
1 organizations
Page 1 / 1